Compensation Committee Uses in Equity Compensation Clause

Equity Compensation from Employment Agreement

This Employment Agreement (the "Agreement"), is effective as of June 16, 2017 (the "Effective Date"), between Aytu BioScience, Inc., a Delaware corporation headquartered at 373 Inverness Parkway, Suite 206, Englewood, CO 80112 USA, hereinafter referred to as the "Company"), and Gregory A. Gould ("Employee").

Equity Compensation. In connection with the execution of this Agreement, the Company hereby agrees to grant on or promptly after August 1, 2017 equity compensation to Employee in the form of options to purchase shares of Company Common Stock. These options shall vest in accordance with the terms and schedule set forth in Exhibit A hereto. Such vesting schedule will be accelerated, to the extent provided in Section 8 of this agreement. Equity grants will be made annually during the Term of this Agreement in the amount approved by the Compensation Committee and commensurate with the performance level of the Employee.

Equity Compensation from Employment Agreement

This EMPLOYMENT AGREEMENT (the "Agreement") is made as of the 28th day of April 2017 (the "Agreement Date"), by and between Great Lakes Dredge & Dock Corporation (the "Corporation"), with and on behalf of its wholly-owned subsidiary, Great Lakes Dredge & Dock Company, LLC ("GLDD LLC") (together, the "Company"), and Lasse Petterson ("Executive").

Equity Compensation. Executive will be eligible to participate in certain equity-based compensation plans established or maintained by the Company for its senior executive officers, including but not limited to the Company's 2007 Long-Term Incentive Plan and any successor thereto. Executive's target long-term incentive ("LTI") grant amount for 2017 shall be Eight Hundred Seventy Thousand Dollars ($870,000), and thereafter shall be set by the Compensation Committee in concert with the Board. For fiscal year 2017, Executive shall be granted the target LTI amount. In addition, Executive shall be eligible to receive the following equity incentives on the six (6) month anniversary of the Start Date:

Equity Compensation from Employment Agreement

This Employment Agreement (the "Agreement"), is effective as of April 16, 2017 (the "Effective Date"), between Aytu BioScience, Inc., a Delaware corporation headquartered at 373 Inverness Parkway, Suite 206, Englewood, CO 80112 USA, hereinafter referred to as the "Company"), and Jarrett T. Disbrow ("Employee").

Equity Compensation. In connection with the execution of this Agreement, the Company hereby agrees to grant on or promptly after August 1, 2017 equity compensation to Employee in the form of options to purchase shares of Company Common Stock. These options shall vest in accordance with the terms and schedule set forth in Exhibit A hereto. Such vesting schedule will be accelerated, to the extent provided in Section 8 of this agreement. Equity grants will be made annually during the Term of this Agreement in the amount approved by the Compensation Committee and commensurate with the performance level of the Employee.

Equity Compensation from Employment Agreement

This Employment Agreement (the "Agreement"), is effective as of April 16, 2017 (the "Effective Date"), between Aytu BioScience, Inc., a Delaware corporation headquartered at 373 Inverness Parkway, Suite 206, Englewood, CO 80112 USA, hereinafter referred to as the "Company"), and Joshua R. Disbrow ("Employee").

Equity Compensation. In connection with the execution of this Agreement, the Company hereby agrees to grant on or promptly after August 1, 2017 equity compensation to Employee in the form of options to purchase shares of Company Common Stock. These options shall vest in accordance with the terms and schedule set forth in Exhibit A hereto. Such vesting schedule will be accelerated, to the extent provided in Section 8 of this agreement. Equity grants will be made annually during the Term of this Agreement in the amount approved by the Compensation Committee and commensurate with the performance level of the Employee.

Equity Compensation from Amended and Restated Employment Agreement

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of March 14, 2017 (the Restatement Date), by and among Cadence Bancorporation, a Delaware corporation (the Company), Cadence Bank, N.A., a national banking association organized under the laws of the United States (the Bank and, together with the Company, Cadence), and Valerie C. Toalson (the Executive).

Equity Compensation. During the Employment Period, the Executive shall be eligible to participate in any equity and/or other long-term compensation programs established by Cadence from time to time for senior executive officers at the discretion of the Compensation Committee.

Equity Compensation from Amended and Restated Employment Agreement

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of March 14, 2017 (the Restatement Date), by and among Cadence Bancorporation, a Delaware corporation (the Company), Cadence Bank, N.A., a national banking association organized under the laws of the United States (the Bank and, together with the Company, Cadence), and Samuel M. Tortorici (the Executive).

Equity Compensation. During the Employment Period, the Executive shall be eligible to participate in any equity and/or other long-term compensation programs established by Cadence from time to time for senior executive officers at the discretion of the Compensation Committee.

Equity Compensation from Employment Agreement

THIS EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of February 1, 2015, by and among Cadence Bancorporation, a Delaware corporation (the Company), Cadence Bank, N.A., a national banking association organized under the laws of the United States (the Bank and, together with the Company, Cadence), and Paul B. Murphy, Jr. (the Executive).

Equity Compensation. During the Employment Period, the Executive shall be eligible to participate in any equity and/or other long-term compensation programs established by Cadence from time to time for senior executive officers at the discretion of the Compensation Committee.

Equity Compensation from Amended and Restated Employment Agreement

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of March 14, 2017 (the Restatement Date), by and among Cadence Bancorporation, a Delaware corporation (the Company), Cadence Bank, N.A., a national banking association organized under the laws of the United States (the Bank and, together with the Company, Cadence), and Rudolph H. Holmes, IV (the Executive).

Equity Compensation. During the Employment Period, the Executive shall be eligible to participate in any equity and/or other long-term compensation programs established by Cadence from time to time for senior executive officers at the discretion of the Compensation Committee.

Equity Compensation from Amended and Restated Employment Agreement

THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of March 14, 2017 (the Restatement Date), by and among Cadence Bancorporation, a Delaware corporation (the Company), Cadence Bank, N.A., a national banking association organized under the laws of the United States (the Bank and, together with the Company, Cadence), and Jack R. Schultz (the Executive).

Equity Compensation. During the Employment Period, the Executive shall be eligible to participate in any equity and/or other long-term compensation programs established by Cadence from time to time for senior executive officers at the discretion of the Compensation Committee.

Equity Compensation from Ceo Employment Agreement

This Interim CEO Employment Agreement (this "Agreement") is entered into effective as of January 9, 2017 (the "Effective Date"), by and between Rent-A-Center, Inc., a Delaware corporation (the "Company"), and Mark E. Speese (the "Interim CEO").

Equity Compensation. The Company will grant the Interim CEO an option to purchase one hundred thousand (100,000) shares of the Company's common stock on or before February 1, 2017 at an exercise price per share equal to the closing price of the Company's common stock on the last market trading day prior to the date of grant. Such grant date will be determined by the Compensation Committee in its discretion. Such option shall be granted pursuant to a Stock Option Agreement, substantially in the form attached hereto as Exhibit A, in accordance with the Company's 2016 Long-Term Incentive Plan.